Igc pharma announces coverage report by ascendiant capital markets about the "reports q3 results. we believe more positive clinical data in 2025 to be strong catalysts for stock.

Potomac, maryland / access newswire / march 12, 2025 / igc pharma, inc. ("igc pharma," "igc," or the "company") (nyse american:igc) announces that ascendiant capital markets has issued a coverage report entitled "reports q3 results. we believe more positive clinical data in 2025 to be strong catalysts for stock.
IGC Ratings Summary
IGC Quant Ranking